drugset / Trial / NCT01653990

Moxifloxacin_QT Study in Chinese Healthy Volunteer

NCT01653990

Unknown 36 enrolled Peking University Third Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

A single-center, randomized, double-blinded, 2-way crossover, placebo-controlled study to assess the QTc interval after administration of single oral dose of 400mg Moxifloxacin in healthy Chinese subjects.

Timeline

Start
2012-07
Primary completion
2012-09
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule 400 mg Oral

Indications